Precision Biopsy, LLC

📍 Aurora, United States👥 5 employees💰 Last funded May 2017
Medical Equipment Manufacturing🌐 precisionbiopsy.com
Website LinkedIn
Precision Biopsy, LLC was formed in partnership with Allied Minds to develop and commercialize novel technology for the accurate diagnosis of prostate cancer. The company’s diagnostic technology uses advanced spectroscopy imaging techniques in combination with tissue biopsy. For the first time, this unique ability will eliminate random prostate biopsies that are subject to sampling errors and can lead to inaccurate grading and staging of the disease. The scientific founders, professors Priya Werahara and John Daily of the University of Colorado, have long studied the morphology of cancer tissue. Combining their knowledge of advanced spectroscopy techniques has resulted in the ability to image the precise location of cancer in the prostate. Precision Biopsy, LLC is a subsidiary of Allied Minds (LSE: ALM), an innovative U.S. science and technology development and commercialization company. More information about Allied Minds can be found at www.alliedminds.com
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Precision Biopsy, LLC?
Precision Biopsy, LLC has 1 investors on record on gritt.io.
When did Precision Biopsy, LLC last raise funding?
The most recent investment in Precision Biopsy, LLC recorded on gritt.io was in May 2017.
What industry is Precision Biopsy, LLC in?
Precision Biopsy, LLC operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Precision Biopsy, LLC based?
Precision Biopsy, LLC is headquartered in Aurora, United States.